Atlanta Braves (BATRA) Notice: 20,000 Series C Shares Proposed Sale

Rhea-AI Filing Summary

Insider sale notice for Atlanta Braves Holdings, Inc. (BATRA) — A Rule 144 notice reports a proposed sale of 20,000 Series C common shares through UBS Financial Services on NASDAQ with an aggregate market value of $820,000. The filer states these shares were acquired on 10/01/2025 by exercise of stock options and paid in cash the same day. The filing also discloses a sale by Jill Robinson of 40,000 Series C shares on 08/15/2025 that generated $1,752,950 in gross proceeds. The filing includes the total number of Series C shares outstanding as 51,459,265 and contains the statutory signature and certification language required under Rule 144.

Positive

• Full disclosure of acquisition method (exercise of stock options) and payment method (cash) for the shares to be sold
• Broker and exchange identified (UBS Financial Services; NASDAQ), supporting trading transparency
• Past sale disclosed (40,000 shares sold on 08/15/2025 for $1,752,950), providing recent transaction history

Negative

• Insider liquidity event: proposed sale of 20,000 Series C shares by an insider could be perceived negatively by some investors
• Concentration of insider sales: prior sale of 40,000 shares plus proposed sale may raise questions about insider selling volume

Insights

Securities Analyst

TL;DR: A company insider plans to sell 20,000 Series C shares acquired by option exercise; prior sale of 40,000 shares was recently reported.

This Rule 144 form notifies the market of a proposed sale of 20,000 Series C common shares via UBS on NASDAQ, showing the holder acquired the shares by exercising options and paid cash on 10/01/2025. The filing also documents a prior sale of 40,000 shares on 08/15/2025 generating $1,752,950. For investors, this is a disclosure of insider liquidity events rather than operational or financial performance information. The listing of 51,459,265 shares outstanding gives context to the size of the proposed sale relative to the total float.

Corporate Governance Expert

TL;DR: Routine Rule 144 disclosure showing compliance with insider sale rules and reporting of recent related transactions.

The document appears to be a standard compliance filing under Rule 144: it specifies acquisition method (option exercise), sale mechanics (broker, exchange), and prior sales by the same account. It includes the required representation about absence of material nonpublic information and signature language. This filing is procedural and informative for governance transparency; it does not, by itself, signal corporate misgovernance or material corporate events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series C Common Stock	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	20000	820000.00	51459265	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series C Common Stock	10/01/2025	Exercise of stock options	Issuer			20000	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jill Robinson 755 Battery Avenue SE Atlanta GA 30339	Series C Common	08/15/2025	40000	1752950.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Rule 144 filing for BATRA report?

The filing reports a proposed sale of 20,000 Series C common shares on NASDAQ.

How were the 20,000 shares acquired according to the filing?

The filing states the shares were acquired on 10/01/2025 by exercise of stock options and paid in cash.

Which broker will handle the proposed sale in the BATRA filing?

The broker identified is UBS Financial Services, Inc., 11 Madison Avenue, New York, NY.

Does the filing disclose any recent related sales?

Yes. It discloses that Jill Robinson sold 40,000 Series C shares on 08/15/2025 for $1,752,950 gross proceeds.

How many Series C shares outstanding does the filing list?

The filing lists 51,459,265 Series C shares outstanding.